n African Journal of Psychiatry - New evidence of agomelatine's efficacy in the treatment of anxiety in depressed patients : product news

Volume 15, Issue 1
  • ISSN : 1994-8220



At the recent 24th European College of Neuropsychopharmacology congress (ECNP) held in early September in Paris, new agomelatine (Valdoxane®) data was presented which highlighted the distinctive profile of agomelatine's efficacy in reducing anxiety symptoms in depression versus placebo and versus active comparators in patients with major depressive disorder.

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error